49827
PT Medela Potentia
Apr 25, 2025
Indonesia
East Asia and the Pacific
Mar 14, 2025
B - Limited
Active
Apr 25, 2025
Regional Industry - MAS Asia & Pac
other
Approved : Feb 20, 2025
Signed : Mar 18, 2025
Invested : Mar 25, 2025
other
PT Medela Potentia (Medela or the Company), is one of Indonesia's largest healthcare and pharmaceutical distribution companies. Medela was established in the 1980s as the distribution arm of PT Dexa Medica (Dexa), a leading pharmaceutical manufacturer in Indonesia. Medela and Dexa (collectively referred to as the Group) are currently owned by the Soetikno family (the Sponsor).
The proposal is for IFC to be a lead investor in the IPO and to invest own account equity in Indonesian Rupiah (“IDR”) of up to a maximum of (i) IDR520 billion (approximately US$35 million equivalent); or (ii) 30% of the total IPO size (the “Project”).
The Company plans to use proceeds from the IPO to expand its operations in Indonesia and to pursue a regional expansion strategy. As a lead investor, IFC will support the Company's IPO and help it to develop its E&S and governance standards.
Additional advisory services are being explored to support Medela’s corporate governance and gender improvement program.
For Inquiries About the Project, Contact
For Inquiries and Comments About IFC, Contact
Local Access of Project Documentation
Indonesia Stock Exchange Bldg,Tower 2, 9th Fl